Aaron Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,197
Closed -$283K 233
2022
Q2
$283K Sell
5,197
-319,147
-98% -$17.5M 0.07% 156
2022
Q1
$5.2M Buy
324,344
+319,836
+7,095% +$21.1M 0.07% 121
2021
Q4
$453K Sell
4,508
-5,346
-54% -$470K 0.13% 108
2021
Q3
$886K Buy
9,854
+21
+0.2% +$1.91K 0.25% 57
2021
Q2
$906K Hold
9,833
0.3% 57
2021
Q1
$950K Sell
9,833
-900
-8% -$92.9K 0.35% 51
2020
Q4
$559K Buy
+10,733
New +$448K 0.2% 69

Other funds holding FLGT

Aaron Wealth Advisors's FLGT Position: Q3 2022 in Review

Aaron Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 5,197 shares — an estimated $283K sold.

Aaron Wealth Advisors first reported a position in FLGT in Q4 2020 and held it in 7 quarters. The position peaked at $5.2M in Q1 2022. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Aaron Wealth Advisors reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Aaron Wealth Advisors sold 5,197 Fulgent Genetics shares in Q3 2022, an estimated $283K.
  • Aaron Wealth Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 7 quarters.
  • Aaron Wealth Advisors's Fulgent Genetics position peaked at $5.2M in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Aaron Wealth Advisors's 13F filing for Q3 2022, filed 21 Oct 2022.